Welcome to our dedicated page for Trulieve Cannabis SEC filings (Ticker: TCNNF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Trulieve Cannabis Corp. filings document the regulatory record of a British Columbia cannabis issuer operating as a vertically integrated multi-state operator in the U.S. Recent Form 8-K reports cover operating results, Regulation FD presentations, material definitive agreements, executive compensation matters, and board or officer transitions.
Proxy filings describe annual meeting matters, director elections, executive compensation, equity awards, and shareholder governance. Debt-related filings disclose senior secured notes due 2030, indenture terms, subsidiary guarantees, and related capital-structure obligations tied to Trulieve and its restricted subsidiaries.
Trulieve Cannabis Corp. reported that Chief Legal Officer Eric Powers received equity-based compensation awards. He was granted stock options for 41,668 subordinate voting shares at an exercise price of $6.40 per share, expiring on March 13, 2033, vesting in three equal annual installments starting December 1, 2026.
Powers also received 58,594 restricted stock units, each representing one subordinate voting share. Half of these RSUs vest on December 1, 2027, and the remaining half on December 1, 2028. Following these awards, he directly owns 245,311 subordinate voting shares, and 1,000 additional shares are held indirectly by his spouse.
Trulieve Cannabis Corp. Chief Technology Officer Nilyum Jhala reported equity compensation awards. Jhala received 58,594 restricted stock units, each representing one subordinate voting share, with 50% vesting on December 1, 2027 and 50% on December 1, 2028.
Jhala was also granted a stock option for 41,668 subordinate voting shares at an exercise price of 6.40 per share, vesting in three equal annual installments on December 1, 2026, December 1, 2027, and December 1, 2028, and expiring on March 13, 2033. Following these awards, Jhala directly owns 239,254 subordinate voting shares and has indirect beneficial ownership of 7,000 shares held by a spouse.
Walsh Brett R. reported acquisition or exercise transactions in this Form 4 filing.
Trulieve Cannabis Corp. reported that Chief Accounting Officer Brett R. Walsh received an equity grant in the form of 28,711 restricted stock units, each representing one subordinate voting share. Half of these RSUs vest on December 1, 2027, and the other half on December 1, 2028. Following this compensation-related award, Walsh directly holds 140,305 subordinate voting shares.
Thronson Susan reported acquisition or exercise transactions in this Form 4 filing.
Trulieve Cannabis Corp. director Susan Thronson received an equity award in the form of restricted stock units (RSUs). The grant covers 23,438 RSUs, each representing a contingent right to receive one Trulieve subordinate voting share at no cash cost.
The RSUs vest on the earliest of the end of her board service, a change of control of Trulieve, or December 1, 2032. Following this award, Thronson holds 64,543 subordinate voting shares directly and 9,740 shares indirectly through the Thronson Family Trust UA.
MILLNER THOMAS L reported acquisition or exercise transactions in this Form 4 filing.
Trulieve Cannabis Corp. director Thomas L. Millner received an equity compensation award in the form of 23,438 subordinate voting share units on March 13, 2026. These units were granted at no cash cost to him and increase his direct holdings to 72,543 shares.
The award is structured as restricted stock units (RSUs), each representing a contingent right to receive one Trulieve subordinate voting share. The RSUs will vest upon the earliest of the end of Millner’s board service, a change of control at Trulieve, or December 1, 2032, tying his compensation to long-term company performance.
Trulieve Cannabis Corp. director Matthew J. Foulston reported an award of 23,438 subordinate voting shares in the form of restricted stock units. These RSUs were granted at no cash cost as equity compensation and increase his direct holdings to 34,767 shares after the transaction.
The footnote explains that each RSU converts into one subordinate voting share, vesting on the earliest of his service ending on the board, a change of control of Trulieve, or December 1, 2032. This is a routine compensation-related equity grant rather than an open-market purchase or sale.
Morreau Jane Cecil reported acquisition or exercise transactions in this Form 4 filing.
Trulieve Cannabis Corp. director Jane Cecil Morreau reported an award of 23,438 Subordinate Voting Shares on 2026-03-13, recorded at $0.00 per share, bringing her reported direct holdings to 65,778 shares.
According to the footnote, this represents a grant of restricted stock units (RSUs), each equal to one Trulieve subordinate voting share. The RSUs will vest on the earliest of the end of her board service, a change of control of Trulieve, or December 1, 2032.
Trulieve Cannabis Corp. director Richard S. May reported an equity compensation grant of 23,438 restricted stock units (RSUs) tied to the company’s subordinate voting shares. The award was recorded at no cash purchase price, reflecting a compensation-related, not open-market, acquisition.
Each RSU represents the right to receive one subordinate voting share. The RSUs will vest on the earliest of the end of May’s board service, a change of control of Trulieve, or December 1, 2032. Following this grant, May directly holds 593,534 subordinate voting shares.
Healy Peter reported acquisition or exercise transactions in this Form 4 filing.
Trulieve Cannabis Corp. director Peter Healy reported an equity compensation grant in the form of restricted stock units (RSUs) covering 23,438 subordinate voting shares. The award was recorded at a price of $0.00 per unit, reflecting a grant rather than a market purchase. Following this grant, Healy is shown as holding 72,673 subordinate voting shares. Each RSU represents a contingent right to receive one Trulieve subordinate voting share and will vest on the earliest of the end of Healy’s board service, a change of control of Trulieve, or December 1, 2032.
Beshears Thad reported acquisition or exercise transactions in this Form 4 filing.
Trulieve Cannabis Corp. director Beshears Thad received an award of 23,438 restricted stock units (RSUs) tied to Subordinate Voting Shares. The grant was reported at a price of zero, indicating a compensation-related award rather than an open‑market purchase.
Each RSU represents the right to receive one Trulieve subordinate voting share. The RSUs will vest on the earliest of the end of his board service, a change of control of Trulieve, or December 1, 2032. After this grant, he directly holds 2,487,043 Subordinate Voting Shares. He also directly holds 15,000 Multiple Voting Shares, which are convertible on a one‑for‑100 basis into an aggregate of 1,500,000 Subordinate Voting Shares.